GlassScriptPhysician profile
Tad Borland
NPI 1225449051
$2,517.93
in general payments reported to CMS, 2019-2025
21 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $97.35 · 2021: $84.17 · 2022: $1,452 · 2023: $306 · 2024: $146 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $1,267.26 | 2022 | |
| Organogenesis INC. | $224.57 | 2019-2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Tactile Systems Technology INC | $213.93 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Smith+Nephew, INC. | $153.83 | 2019-2023 | Stravix Pl, Regranex |
| Acera Surgical, INC. | $124.35 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $73.77 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Misonix INC | $72.07 | 2019-2020 | |
| Kci USA, INC. | $67.49 | 2020-2022 | |
| Nevro Corp. | $43.94 | 2021-2023 | Senza |
| Innovation Technologies INC | $40.91 | 2023 | Irrisept |
| Integra Lifesciences Corporation | $39.04 | 2019-2022 | |
| Stryker Corporation | $34.38 | 2022 | |
| Bioventus LLC | $28.70 | 2022 | |
| Horizon Therapeutics Plc | $25.85 | 2019 | |
| Solventum Corporation | $22.02 | 2024 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Promogran Prisma |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hartmann USA, INC. | $20.16 | 2022 | |
| Hydrofera LLC | $17.81 | 2025 | Hydrofera Blue |
| Arthrosurface Incorporated | $12.47 | 2020 | |
| Depuy Synthes Sales INC. | $12.44 | 2019 | |
| Boston Scientific Corporation | $11.79 | 2019 | |
| Nabriva Therapeutics, Plc | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tad Borland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.